ReviewVascular health and risk management2012

Evidence to support the use of vildagliptin monotherapy in the treatment of type 2 diabetes mellitus.

Sylvie Dejager et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.